BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28976789)

  • 1. Estimating asthma control questionnaire (ACQ) scores from claims data.
    Sullivan PW; Ghushchyan VH; Globe G
    J Asthma; 2018 Sep; 55(9):1002-1010. PubMed ID: 28976789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring asthma control cutoffs and economic outcomes using the Asthma Control Questionnaire.
    Sullivan PW; Globe G; Ghushchyan VH; Campbell JD; Bender B; Magid DJ
    Ann Allergy Asthma Immunol; 2016 Sep; 117(3):251-257.e2. PubMed ID: 27613458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring the cost of poor asthma control and exacerbations.
    Sullivan PW; Ghushchyan VH; Campbell JD; Globe G; Bender B; Magid DJ
    J Asthma; 2017 Jan; 54(1):24-31. PubMed ID: 27286240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The truth about SABA pharmacy claims--results from a prospective study.
    Chernicoff HO
    Manag Care; 2004 Jul; 13(7 Suppl Reversing Asthma):9-11; discussion 17-9. PubMed ID: 18564547
    [No Abstract]   [Full Text] [Related]  

  • 5. Characterizing the severe asthma population in the United States: claims-based analysis of three treatment cohorts in the year prior to treatment escalation.
    Sullivan PW; Campbell JD; Ghushchyan VH; Globe G; Lange J; Woolley JM
    J Asthma; 2015 Sep; 52(7):669-80. PubMed ID: 25731600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with the control of severe asthma.
    Hermosa JL; Sánchez CB; Rubio MC; Mínguez MM; Walther JL
    J Asthma; 2010 Mar; 47(2):124-30. PubMed ID: 20170317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the Spanish version of the Asthma Control Questionnaire.
    Picado C; Badiola C; Perulero N; Sastre J; Olaguíbel JM; López Viña A; Vega JM;
    Clin Ther; 2008 Oct; 30(10):1918-31. PubMed ID: 19014848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective claims study of fluticasone propionate/salmeterol fixed-dose combination use as initial asthma controller therapy in children despite guideline recommendations.
    Friedman HS; Eid NS; Crespi S; Wilcox TK; Reardon G
    Clin Ther; 2009 May; 31(5):1056-63. PubMed ID: 19539106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids.
    Friedman HS; Yawn BP
    Curr Med Res Opin; 2007 Feb; 23(2):427-34. PubMed ID: 17288696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication use and indicators of poor asthma control in patients with and without allergies.
    Sullivan PW; Lanz MJ; Ghushchyan VH; Kavati A; LeCocq J; Ortiz B; Maselli DJ
    Allergy Asthma Proc; 2019 Jul; 40(4):221-229. PubMed ID: 31053178
    [No Abstract]   [Full Text] [Related]  

  • 11. Concordance of Medicaid and pharmacy record data in inner-city children with asthma.
    Mudd KE; Bollinger ME; Hsu VD; Manning A; Tsoukleris MG; Butz AM
    Contemp Clin Trials; 2008 Jan; 29(1):13-20. PubMed ID: 17574930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Medicaid patients with asthma: comparison with treatment guidelines using disease-based drug utilization review methodology.
    Laumann JM; Bjornson DC
    Ann Pharmacother; 1998 Dec; 32(12):1290-4. PubMed ID: 9876808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atopy is not associated with poor control of asthma.
    Ponte EV; Souza-Machado A; Souza-Machado C; Franco R; Cruz AA
    J Asthma; 2012 Dec; 49(10):1021-6. PubMed ID: 23098410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can severe asthmatic patients achieve asthma control? A systematic approach in patients with difficult to control asthma followed in a specialized clinic.
    Athanazio R; Carvalho-Pinto R; Fernandes FL; Rached S; Rabe K; Cukier A; Stelmach R
    BMC Pulm Med; 2016 Nov; 16(1):153. PubMed ID: 27852260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An assessment of change in asthma control among adolescents and adults with persistent asthma in mometasone furoate/formoterol fumarate clinical trials.
    Wyrwich KW; Ireland AM; Navaratnam P; Nolte H; Gates DF
    J Asthma; 2011 Feb; 48(1):48-56. PubMed ID: 21039190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnitude of effect of asthma treatments on Asthma Quality of Life Questionnaire and Asthma Control Questionnaire scores: Systematic review and network meta-analysis.
    Bateman ED; Esser D; Chirila C; Fernandez M; Fowler A; Moroni-Zentgraf P; FitzGerald JM
    J Allergy Clin Immunol; 2015 Oct; 136(4):914-22. PubMed ID: 25936565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a claims-based algorithm to identify moderate exacerbations in patients with asthma treated in the US.
    Roberts MH; Duh MS; Rothnie KJ; Zhang S; Czira A; Slade D; Cheng WY; Thompson-Leduc P; Greatsinger A; Zhang A; Mapel D
    Respir Med; 2024 May; 226():107630. PubMed ID: 38593886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting beta2-agonists: addition of montelukast in an open-label pilot study.
    Dupont L; Potvin E; Korn D; Lachman A; Dramaix M; Gusman J; Peché R;
    Curr Med Res Opin; 2005 Jun; 21(6):863-9. PubMed ID: 15969886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between asthma drug therapy patterns and healthcare utilization.
    Shireman TI; Heaton PC; Gay WE; Cluxton RJ; Moomaw CJ
    Ann Pharmacother; 2002 Apr; 36(4):557-64. PubMed ID: 11918499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life and measures of asthma control in primary health care.
    Lisspers K; Ställberg B; Hasselgren M; Johansson G; Svärdsudd K
    J Asthma; 2007 Nov; 44(9):747-51. PubMed ID: 17994405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.